Prothena to Participate in Upcoming Healthcare Conferences

Rhea-AI Summary

Prothena Corporation plc (PRTA) announced senior management's participation in upcoming investor conferences. The company will be present at Leerink Partners Global Biopharma Conference on March 12 and Jefferies Biotech on the Bay Summit on March 13. A webcast of the fireside chat will be available on the company's website.

DUBLIN--(BUSINESS WIRE)-- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that members of its senior management team will participate in the following upcoming investor conferences:

• Leerink Partners Global Biopharma Conference on Tuesday, March 12; a fireside chat will be held at 10:00 AM ET
• Jefferies Biotech on the Bay Summit on Wednesday, March 13; 1x1 investor meetings will be held

A live webcast of the fireside chat can be accessed through the investor relations section of the Company's website at www.prothena.com. Following the live presentation, a replay of the webcast will be available on the Company's website for 90 days following the presentation date.

About Prothena

Prothena Corporation plc is a late-stage clinical biotechnology company with expertise in protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare peripheral amyloid diseases. Fueled by its deep scientific expertise built over decades of research, Prothena is advancing a pipeline of therapeutic candidates for a number of indications and novel targets for which its ability to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins can be leveraged. Prothena’s pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and a number of other neurodegenerative diseases. For more information, please visit the Company’s website at www.prothena.com and follow the Company on Twitter @ProthenaCorp.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240305018397/en/

Investors

Mark Johnson, CFA, Vice President, Investor Relations

650-417-1974, mark.johnson@prothena.com

Media

Michael Bachner, Senior Director, Corporate Communications

609-664-7308, michael.bachner@prothena.com

Source: Prothena Corporation plc

When will Prothena Corporation plc's senior management team participate in the Leerink Partners Global Biopharma Conference?

Prothena Corporation plc's senior management team will participate in the Leerink Partners Global Biopharma Conference on Tuesday, March 12.

Where can investors access the webcast of the fireside chat?

Investors can access the webcast of the fireside chat through the investor relations section of Prothena Corporation plc's website at www.prothena.com.

For how long will the replay of the webcast be available on the company's website?

The replay of the webcast will be available on Prothena Corporation plc's website for 90 days following the presentation date.